CHAIRS
Roger S. Blumenthal, MD Associate Professor of Medicine Johns Hopkins University School of Medicine Director of Preventive Cardiology The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Johns Hopkins University School of Medicine Baltimore, Maryland • Dr Blumenthal reports receiving grants and/or research support from Merck, Pfizer, Wyeth-Ayerst, Bristol-Myers Squibb, and Novartis; and has received honoraria from Merck, Pfizer, Medcom, and Physician's World.
Peter O. Kwiterovich, Jr, MD Professor of Medicine and Pediatrics Johns Hopkins University School of Medicine Director, Johns Hopkins University Lipid Clinic Chief, Lipid Research Johns Hopkins University Hospital Baltimore, Maryland • Dr Kwiterovich reports receiving grants and/or research support from AstraZeneca, Merck, Kos, and Pfizer; serving as a consultant to and receiving honoraria from Merck, Sankyo Pharma, and Kos.
PARTICIPATING FACULTY
Bassem El-Masri, MD Assistant Professor of Clinical Medicine and Cardiology Director, Cardiac Prevention and Intervention Center Weill Medical College of Cornell University and New York Presbyterian Hospital New York, New York • Dr El-Masri reports serving as a consultant to Merck, Bristol-Myers Squibb, Pfizer, Novartis, GlaxoSmithKline, Sankyo, KOS, AstraZeneca, Bayer, Atherotec, and Lipomed; serving on the speakers bureau for KOS, GlaxoSmithKline, and Sankyo; and receiving grant/research support from Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Liposome, Merck, Novartis, and Schering-Plough.
Sherita Hill Golden, MD, MHS Assistant Professor of Endocrinology Johns Hopkins University School of Medicine Baltimore, Maryland • Dr Golden reports receiving grants and/or research support from The Robert Wood Johnson Foundation.
Howard Knapp, MD, PhD Executive Director Deaconess Billings Clinic Billings, Montana • Dr Knapp reports receiving grants and/or research support from Pfizer, Merck, Novartis, Knoll, Amgen, Bayer, Bristol-Myers Squibb, SmithKline Beecham, Pharmacia, Aventis, Wyeth-Ayerst, Schering-Plough, and Sankyo Pharma; and receiving honoraria from Roche, Bayer, and Sankyo Pharma.
William C. Little, MD Chief, Cardiology Section Wake Forest University Baptist Medical Center Winston-Salem, North Carolina • Dr Little reports receiving grants and/or research support from Merck; and serving as a consultant to Merck and Sankyo.
James J. Maciejko, MD, PhD Director of Preventive Cardiology St. Johns Hospital Detroit, Michigan • Dr Maciejko reports receiving grants and/or research support from Merck, Pfizer, Beckman-Coulter, and Roche; and receiving honoraria from Sankyo Pharma, Pfizer, Merck, Kos, DuPont, and Abbott.
David G. Robertson, MD Assistant Clinical Professor Emory University School of Medicine Physician, Atlanta Diabetes Associates Atlanta, Georgia • Dr Robertson reports serving as a consultant for Kos and Abbott; and receiving honoraria from Pfizer, Bristol-Myers Squibb, and Sankyo Pharma.
Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies. |